Abstract:Insulin is a protein hormone secreted by pancreatic,6 cells. One of its main functions is to keep the balance of glucose inside the body by regulating the absorption and metabolism of glucose in the periphery tissue, as well as the production and storage of hepatic glycogen. The insulin receptor is a transmembrane glycoprotein in which two a subunits with a molecular weight of 135 kD and two beta subunits with a molecular weight of 95 kD are joined by a disulfide bond to form a beta-alpha-alpha-beta structure. The extracellular a subunit, especially, its three domains near the N-terminal are partially responsible for signal transduction or ligand-binding, as indicated by the experiments. The extracellular a subunits are involved in binding the ligands. The experimental results indicate that the three domains of the N-terminal of the a subunits are the main determinative parts of the insulin receptor to bind the insulin or mimetic peptide. We employed the extracellular domain(PDBID: 11GR) of the insulin-like growth factor-1 receptor(IGF-1R) as the template to simulate and optimize the spatial structures of the three domains in the extracellular domain of the insulin receptor, which includes 468 residues. The work was accomplished by making use of the homology program in the Insight U package on an Origin3800 server. The docking calculations of the insulin receptor obtained by homology with hexapeptides were carried out by means of the program Affinity. The analysis indicated that there were hydrogen bonding, and electrostatic and hydrophobic effects in the docking complex of the insulin receptor with hexapeptides. Moreover, we described the spatial orientation of a mimetic peptide with agonist activity in the docking complex. We obtained a rough model of binding of DLAPSQ or STIVYS with the insulin receptor, which provides the powerful theoretical support for designing the minimal insulin mimetic peptide with agonist activity, making it possible to develop oral small molecular hypoglycemic drugs.

Affinity Chromatography of Insulin with a Heptapeptide Ligand Selected from Phage Display Library

Affinity Purification of Insulin by Peptide-Ligand Affinity Chromatography

Tetrapeptide Ligands Screening for Antibody Separation and Purification by Molecular Simulation and Experimental Verification

A New Tetrapeptide Biomimetic Chromatographic Resin for Antibody Separation with High Adsorption Capacity and Selectivity

Antibody-ligand Interactions for Hydrophobic Charge-Induction Chromatography: a Surface Plasmon Resonance Study.

New Tetrapeptide Ligands Designed for Antibody Purification with Biomimetic Chromatography: Molecular Simulation and Experimental Validation

Development of a Hybrid Biomimetic Ligand with High Selectivity and Mild Elution for Antibody Purification

Solid Phase Synthesis of Peptide as Affinity Ligand

Analysis of Interaction Between Insulin and Its Receptor by Biofunctional Chromatography

Binding Mode of Insulin Receptor and Agonist Peptide

Identification of Insulin Mimetics from a Phage-displayed Library

Rational design of affinity peptide ligand by flexible docking simulation.

Combinatorial libraries of bipodal binders of the insulin receptor

Screening Affinity Ligands of Α-Amylase from a Heptapeptide Phage Display Library

Molecularly Imprinted Polymer for Selective Insulin Capture and Separation

Molecular Recognition of Insulin by a Synthetic Receptor

Affinity Chromatography of Human IgG with Octapeptide Ligands Identified from Eleven Peptide-Ligand Candidates

Octapeptide-based Affinity Chromatography of Human Immunoglobulin G: Comparisons of Three Different Ligands.

An Alternating Elution Strategy for Screening High Affinity Peptides from a Phage Display Peptide Library

Discovery of a Polystyrene Binding Peptide Isolated from Phage Display Library and Its Application in Peptide Immobilization

Selection of affinity ligands for protein purification from proteolytic digests